Many cancer cells, including e.g. prostate, breast, and colon cancer or melanoma, may produce large amounts of IL-6 and express the IL-6R/gp80 and gp130 receptor subunits, which allow them to respond to IL-6 stimulation even in an autocrine manner [13]. Here, IL6R is linked to malignant colon neoplasm.